301333 logo

R&G PharmaStudies Co., Ltd. Stock Price

SZSE:301333 Community·CN¥6.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

301333 Share Price Performance

CN¥63.76
17.81 (38.76%)
CN¥63.76
17.81 (38.76%)
Price CN¥63.76

301333 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with limited growth.

0 Risks
2 Rewards

R&G PharmaStudies Co., Ltd. Key Details

CN¥896.3m

Revenue

CN¥597.9m

Cost of Revenue

CN¥298.4m

Gross Profit

CN¥164.7m

Other Expenses

CN¥133.7m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
1.39
33.29%
14.91%
1.8%
View Full Analysis

About 301333

Founded
2008
Employees
2645
CEO
Jie Wu
WebsiteView website
www.rg-pharma.com

R&G PharmaStudies Co., Ltd. operates as a clinical trial outsourcing service provider in China and internationally. It offers drug clinical research and development integrated services. The company’s services include clinical trial operation, clinical trial site management, biological sample testing, data management and statistical analysis, clinical trial consulting, and clinical pharmacology services. It serves pharmaceutical and medical device companies, and scientific research institutions. The company was founded in 2008 and is headquartered in Beijing, China.

Recent 301333 News & Updates

Recent updates

No updates